Pharma News, 2024

India is the largest supplier of generic medicines with around 20 per cent share in the global supply by manufacturing 60,000 different generic brands across 60 therapeutic categories.

AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

(Bloomberg) -- About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater access to its human insulin and lower prices, while al...

The FDA has approved an adeno-associated virus vector-based gene therapy to treat both adult and pediatric patients with aromatic L-amino acid decarboxylase deficiency.

Pfizer explores sale of hospital drugs unit amid activist investor’s call for accountability: Reuters

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V

With high hopes for the economy, AstraZeneca adds $2B to US investment in manufacturing, R&D

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & Johnson‘s (J&J) nipocalimab for treating individuals with...

Preclinical + International Congress for Ataxia Research

FDA Takes Step Toward Removal of Ineffective Decongestants From the Market

Eisai lowers Leqembi revenue forecast after rocky entry to market